Case Name (Date)

Smith et al. v. GlaxoSmithKline, PLC and GlaxoSmithKline Consumer Healthcare
21-cv-9390, N.D. Cal.
(Dec. 2021)


Product/Service

Abreva cold sore treatment cream


Allegations

Falsely marketing that the product heals cold sores in two and a half days when scientific evidence shows it does not work as advertised

Misleadingly marketing that “[n]othing heals a cold sore faster” when other products claim to heal cold sores in less time

Marketing that the product shortens healing time and provides anti-viral benefits without FDA approval to do so


Status

Pending



Class-Action Tracker

ChapStick Natural Claims

Class Action

ChapStick Natural Claims

In December 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare Holdings and Pfizer for allegedly falsely advertising ChapStick products as natural when, according to plaintiffs, the products contain…

Benefiber Prebiotic Supplement

Class Action

Benefiber Prebiotic Supplement

In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…

Boostrix

Class Action

Boostrix

In May 2020, a class-action lawsuit was filed against GlaxoSmithKline for allegedly falsely advertising the medication Boostrix in what has been referred to as “The Big Bad Cough” advertising campaign.…

Total Hydration ChapStick

Class Action

Total Hydration ChapStick

December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…

Chapstick Lip Balms with Sunscreen

Class Action

Chapstick Lip Balms with Sunscreen

In May 2019, a class-action lawsuit was filed against Wyeth Consumer Healthcare for allegedly misleadingly marketing – on the front of the package — that its Chapstick lip balm-sunscreen products…


The Latest

Filters


Show More